78 related articles for article (PubMed ID: 9751111)
1. Pulse versus oral cyclophosphamide in the treatment of Wegener's granulomatosis: comment on the article by Guillevin et al.
Langford CA; Sneller MC
Arthritis Rheum; 1998 Sep; 41(9):1706-9. PubMed ID: 9751111
[No Abstract] [Full Text] [Related]
2. Questions regarding the design of the study of pulse versus oral cyclophosphamide in the treatment of Wegener's granulomatosis: comment on the article by Guillevin et al.
Stone JH; Hellmann DB
Arthritis Rheum; 1998 Sep; 41(9):1705-6; author reply 1707-9. PubMed ID: 9751110
[No Abstract] [Full Text] [Related]
3. Respiratory failure in Wegener's granulomatosis: response to pulse intravenous methylprednisolone and cyclophosphamide.
Chapman PT; O'Donnell JL
J Rheumatol; 1993 Mar; 20(3):504-6. PubMed ID: 8478858
[TBL] [Abstract][Full Text] [Related]
4. A brief history of Wegener's granulomatosis: on limited, localized, and generalized forms of the disease: comment on the article by the Wegener's Granulomatosis Etanercept Trial Research Group.
Lamprecht P; Gross WL
Arthritis Rheum; 2004 Jan; 50(1):334-5; author reply 335-6. PubMed ID: 14730635
[No Abstract] [Full Text] [Related]
5. Successful treatment with intravenous cyclophosphamide pulse therapy of severe intestinal involvement in Wegener's granulomatosis.
Kuwahara Y; Shima Y; Tanaka T; Kimura H; Hoshida Y; Aozasa K; Kawase I
Scand J Rheumatol; 2006; 35(3):243-5. PubMed ID: 16766375
[No Abstract] [Full Text] [Related]
6. Wegener's granulomatosis with massive skin necrosis.
Cybulska A; Undas A; Sydor WJ; Flak A; Musial A
J Rheumatol; 2004 Apr; 31(4):830-1. PubMed ID: 15095749
[No Abstract] [Full Text] [Related]
7. [How long should cyclophosphamide therapy of Wegener's granulomatosis continue?].
Reinhold-Keller E
Dtsch Med Wochenschr; 2002 Sep; 127(37):1909-10. PubMed ID: 12226791
[No Abstract] [Full Text] [Related]
8. Current state of tumour necrosis factor {alpha} blockade in Wegener's granulomatosis.
Mukhtyar C; Luqmani R
Ann Rheum Dis; 2005 Nov; 64 Suppl 4(Suppl 4):iv31-6. PubMed ID: 16239383
[TBL] [Abstract][Full Text] [Related]
9. Etanercept combined with conventional treatment in Wegener's granulomatosis: a six-month open-label trial to evaluate safety.
Stone JH; Uhlfelder ML; Hellmann DB; Crook S; Bedocs NM; Hoffman GS
Arthritis Rheum; 2001 May; 44(5):1149-54. PubMed ID: 11352248
[TBL] [Abstract][Full Text] [Related]
10. Malignancies and cyclophosphamide exposure in Wegener's granulomatosis.
Bernatsky S; Ramsey-Goldman R; Clarke AE
J Rheumatol; 2008 Jan; 35(1):11-3. PubMed ID: 18176988
[No Abstract] [Full Text] [Related]
11. Wegener's granulomatosis presenting as unilateral parotid enlargement.
Chegar BE; Kelley RT
Laryngoscope; 2004 Oct; 114(10):1730-3. PubMed ID: 15454762
[TBL] [Abstract][Full Text] [Related]
12. Intravenous pulse administration of cyclophosphamide versus daily oral treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitis and renal involvement: a prospective, randomized study.
Haubitz M; Schellong S; Göbel U; Schurek HJ; Schaumann D; Koch KM; Brunkhorst R
Arthritis Rheum; 1998 Oct; 41(10):1835-44. PubMed ID: 9778225
[TBL] [Abstract][Full Text] [Related]
13. Intravenous pulse versus oral administration of cyclophosphamide: comment on the article by Haubitz et al.
Savage CO; Jayne DR
Arthritis Rheum; 1999 Sep; 42(9):2019-20. PubMed ID: 10513825
[No Abstract] [Full Text] [Related]
14. Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide.
Knight A; Askling J; Granath F; Sparen P; Ekbom A
Ann Rheum Dis; 2004 Oct; 63(10):1307-11. PubMed ID: 15130900
[TBL] [Abstract][Full Text] [Related]
15. Update on the treatment of Wegener's granulomatosis.
Esper GJ; Johnson JS
Bull Rheum Dis; 1999; 48(11):1-4. PubMed ID: 10721552
[TBL] [Abstract][Full Text] [Related]
16. Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis.
Metzler C; Miehle N; Manger K; Iking-Konert C; de Groot K; Hellmich B; Gross WL; Reinhold-Keller E;
Rheumatology (Oxford); 2007 Jul; 46(7):1087-91. PubMed ID: 17519271
[TBL] [Abstract][Full Text] [Related]
17. Meningeal involvement in Wegener's granulomatosis.
Al Dhanhani A; Macaulay R; Maloney B; Hanly JG
J Rheumatol; 2006 Feb; 33(2):364-7. PubMed ID: 16465672
[TBL] [Abstract][Full Text] [Related]
18. Malignancies in Wegener's granulomatosis: incidence and relation to cyclophosphamide therapy in a cohort of 293 patients.
Faurschou M; Sorensen IJ; Mellemkjaer L; Loft AG; Thomsen BS; Tvede N; Baslund B
J Rheumatol; 2008 Jan; 35(1):100-5. PubMed ID: 17937462
[TBL] [Abstract][Full Text] [Related]
19. Leflunomide versus methotrexate in Wegener's granulomatosis.
Jayne D
Rheumatology (Oxford); 2007 Jul; 46(7):1047-8. PubMed ID: 17409129
[No Abstract] [Full Text] [Related]
20. Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial.
Stone JH;
Arthritis Rheum; 2003 Aug; 48(8):2299-309. PubMed ID: 12905485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
